Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 3Other hematologic neoplasm 3Lymphoid 3Myeloid 2

Conditions

Myelodysplastic Syndromes 144Leukemia, Myeloid, Acute 133Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Leukemia, Myelogenous, Chronic, BCR-ABL Positive 67Leukemia 52Hodgkin Disease 49Lymphoma, Non-Hodgkin 47Multiple Myeloma 43Myeloproliferative Disorders 39Lymphoma 36Leukemia, Lymphocytic, Chronic, B-Cell 36Primary Myelofibrosis 24Leukemia, Biphenotypic, Acute 22Leukemia, Myelomonocytic, Chronic 21Hematologic Neoplasms 20Graft vs Host Disease 18Anemia, Refractory, with Excess of Blasts 17Anemia, Aplastic 14Lymphoma, Mantle-Cell 13Lymphoma, Follicular 13Lymphoma, B-Cell, Marginal Zone 13Burkitt Lymphoma 13Neoplasms, Plasma Cell 12Leukemia, Prolymphocytic 11Blast Crisis 10Polycythemia Vera 8Leukemia, Myelomonocytic, Juvenile 8Hematologic Diseases 8Leukemia, Lymphoid 7Thrombocythemia, Essential 6

Interventions

fludarabine 2Tacrolimus 2fludarabine phosphate 1Whole-Body Irradiation 1Stem Cell Transplantation 1Mycophenolic Acid 1Cyclophosphamide 1Busulfan 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Paraproteinemias × fludarabine × Myeloid × Clear all
NCT02556931 2022-11-03

Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
117 enrolled 27 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Paraproteinemias, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myelomonocytic, Chronic, Neoplasms, Plasma Cell, Primary Myelofibrosis

NCT00579111 2016-05-04

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Baylor College of Medicine

Phase 1/2 Terminated
4 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Paraproteinemias, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡